Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials.

Egen, Jackson G; Ouyang, Wenjun; Wu, Lawren C

Egen, Jackson G; Ouyang, Wenjun; Wu, Lawren C.

Affiliation

Egen JG; Department of Inflammation and Oncology, Amgen Research, Amgen, Inc., South San Francisco, CA 94080, USA. Electronic address: jegen@amgen.com.
Ouyang W; Department of Inflammation and Oncology, Amgen Research, Amgen, Inc., South San Francisco, CA 94080, USA.
Wu LC; Department of Inflammation and Oncology, Amgen Research, Amgen, Inc., South San Francisco, CA 94080, USA. Electronic address: lawrenw@amgen.com.

Immunity ; 52(1): 36-54, 2020 01 14.

Article in En | MEDLINE | ID: mdl-31940272

Subject(s)

Antibodies, Monoclonal/therapeutic use; Immunotherapy/methods; Neoplasms/therapy; T-Lymphocytes/immunology; B7-H1 Antigen/antagonists & inhibitors; CTLA-4 Antigen/antagonists & inhibitors; Humans; Lymphocyte Activation/immunology; Neoplasms/immunology; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Tumor Microenvironment/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy / Antibodies, Monoclonal / Neoplasms Limits: Humans Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google